| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |